News
HQH
16.86
+0.24%
0.04
Weekly Report: what happened at HQH last week (0318-0322)?
Weekly Report · 3d ago
Weekly Report: what happened at HQH last week (0311-0315)?
Weekly Report · 03/18 09:01
Weekly Report: what happened at HQH last week (0304-0308)?
Weekly Report · 03/11 09:01
I Am Loading Up On 2 Bargain Fat Dividends
Seeking Alpha · 03/07 12:35
Weekly Report: what happened at HQH last week (0226-0301)?
Weekly Report · 03/04 09:01
HQH: Healthcare Fund With 11% Income And A High Discount
Abrdn Healthcare Investors is a closed-end fund that invests in a portfolio of common stocks in the healthcare industry, heavily weighted in biotechnology. The HQH CEF currently provides a very high yield of 11% plus a high discount of -15% to NAV. HQH has a solid long-term record of nearly 37 years, nearly matching the performance of the S&P 500.
Seeking Alpha · 03/03 14:00
How To Invest In A SWAN Portfolio: The Near Perfect Portfolio Strategy
The Near Perfect Portfolio Strategy provides SWAN-like attributes and aims to meet income and growth goals while minimizing volatility and drawdowns. Backtesting results over 17 years show the strategy has the potential to outperform the S&P 500. The strategy consists of three buckets: Dividend Growth Investing, High Income and Hedging.
Seeking Alpha · 03/02 14:00
Weekly Report: what happened at HQH last week (0219-0223)?
Weekly Report · 02/26 09:01
Yes, You Can Retire On Dividends, 2 Fat Yields Up To 10%
Southern California Edison is one of the largest electric utilities in the United States. The company has raised its dividend by 5.8% in the past year. The preferred shares of SCE pay up to 6% and have a dividend yield of up to 10%. Rida Morwa says you can retire on dividends and live off the income your portfolio produces.
Seeking Alpha · 02/25 15:30
Abrdn Healthcare Investors (HQH) Declares $0.48 Dividend
NASDAQ · 02/21 01:58
The abrdn Healthcare Opportunities Fund Is Due For A Breakout
Seeking Alpha · 02/20 16:00
Weekly Report: what happened at HQH last week (0212-0216)?
Weekly Report · 02/19 09:01
Tuesday Is Your Last Chance To Buy Tekla Healthcare Before The Dividend Payout
Tekla Healthcare announced a quarterly dividend of 48 cents per share on Friday. The company's stock will go ex-dividend on Wednesday. Tuesday marks the last chance for investors to receive the next dividend payout from Tekla Healthcare. The stock will likely open 48 cents lower to reflect the payout.
Benzinga · 02/16 14:45
Weekly Report: what happened at HQH last week (0205-0209)?
Weekly Report · 02/12 09:01
abrdn Healthcare Investors raises dividend by 26.3% to $0.48
Abrdn Healthcare Investors raises dividend by 26.3% to $0.48. Forward yield 11.21% Payable March 28. The Board has determined the rolling distribution rate for HQH to be increased by 25% to 10% for the 12-month period.
Seeking Alpha · 02/12 07:27
Weekly Report: what happened at HQH last week (0129-0202)?
Weekly Report · 02/05 09:01
HQH: Disappointing Track Record
Abrdn Healthcare Investors (HQH) fund has a 36-year track record of underperforming peers. HQH focuses on mid and large-cap biotech and pharmaceutical companies in late-stage clinical trials. The fund is focused on the healthcare sector. The portfolio has a 9% upside potential.
Seeking Alpha · 02/04 12:58
I Am Bottom Fishing: 2 Great Dividends +9%
Seeking Alpha · 01/31 12:35
Weekly Report: what happened at HQH last week (0122-0126)?
Weekly Report · 01/29 09:01
The 8% Income Portfolio: 2023 Year-End Review
The 8% Income Portfolio: 2023 year-end review of our 8% income portfolio. The tech stocks and the "Magnificent Seven" performed extremely well in the year 2023. The portfolio earned over $29,000 in distributions amounting to over 14% yield-on-cost basis and roughly 8.6% on average portfolio value. This portfolio was launched in October 2014.
Seeking Alpha · 01/26 14:00
More
Webull provides a variety of real-time HQH stock news. You can receive the latest news about abrdn Healthcare Investors through multiple platforms. This information may help you make smarter investment decisions.
About HQH
Tekla Life Sciences Investors (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is long-term capital appreciation through investment in the United States and foreign companies in the life sciences industry, including biotechnology, pharmaceutical, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices and supplies, agriculture, and environmental management. The Fund invests primarily in securities of public and private companies, which have potential for above-average growth. The Fund may invest up to 20% of its net assets in securities of foreign issuers, located primarily in Western Europe, Canada and Japan, and securities of the United States issuers that are traded primarily in foreign markets. The Fund's investment advisor is Tekla Capital Management LLC.